Down-regulated MYH11 expression correlates with poor prognosis in stage II and III colorectal cancer

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 17, 2014, Pages 7223-7228

  Wang, Ren Jie ^a,b   Wu, Peng ^a,b   Cai, Guo Xiang ^a,b   Wang, Zhi Min ^a,b   Xu, Ye ^a,b   Peng, Jun Jie ^a,b   Sheng, Wei Qi ^a,b   Lu, Hong Fen ^a,b   Cai, San Jun ^a,b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Colorectal cancer; Immunohistochemistry; MYH11; Prognosis; Realtime PCR

Indexed keywords

MESSENGER RNA; MYH11 PROTEIN, HUMAN; MYOSIN HEAVY CHAIN;

AGED; CANCER STAGING; CARCINOMA; COLORECTAL NEOPLASMS; DISEASE FREE SURVIVAL; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; PATHOLOGY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION;

AGED; CARCINOMA; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MYOSIN HEAVY CHAINS; NEOPLASM STAGING; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84907274387     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.17.7223     Document Type: Article

References (43)

1. Alhopuro P, Phichith D, Tuupanen S, et al (2008). Unregulated smooth-muscle myosin in human intestinal neoplasia. Proc Natl Acad Sci USA, 105, 5513-8.
2. Aschele C, Bergamo F, Lonardi S (2009). Chemotherapy for operable and advanced colorectal cancer. Cancer Treat Rev, 35, 509-16.
3. Atrkar-Roushan Z, Kazemnejad A, Mansour-Ghanaei F, et al (2013). Trend analysis of gastrointestinal cancer incidences in Guilan province: comparing rates over 15 years. Asian Pac J Cancer Prev, 14, 7587-93.
4. Chen Q, Xia HW, Ge XJ, et al (2013). Serum miR-19a predicts resistance to FOLFOX chemotherapy in advanced colorectal cancer cases. Asian Pac J Cancer Prev, 14, 7421-6.
5. Chibalina MV, Puri C, Kendrick-Jones J, et al (2009). Potential roles of myosin VI in cell motility. Biochem Soc T, 37, 966-70.
6. Compton C, Fenoglio-Preiser CM, Pettigrew N, et al (2000). American joint committee on cancer prognostic factors consensus conference. Cancer, 88, 1739-57.
7. Cserni G (2003). Nodal staging of colorectal carcinomas and sentinel nodes. J Clin Pathol, 56, 327-35.
8. Cui WJ, Liu Y, Zhou XL, et al (2010). Myosin light chain kinase is responsible for high proliferative ability of breast cancer cells via anti-apoptosis involving p38 pathway. Acta Pharmacol Sin, 31, 725-32.
9. Cui YL, Li HK, Zhou HY, et al (2013). Correlations of tumor-associated macrophage subtypes with liver metastases of colorectal cancer. Asian Pac J Cancer Prev, 14, 1003-7.
10. De Dosso S, Sessa C, Saletti P (2009). Adjuvant therapy for colon cancer: present and perspectives. Cancer Treat Rev, 35, 160-6.
11. de Gramont A, Tournigand C, André T, et al Adjuvant therapy for stage II and III colorectal cancer. Semin Oncol, 2007, 37.
12. Deng BG, Yao JH, Liu QY, et al (2013). Comparative serum proteomic analysis of serum diagnosis proteins of colorectal cancer based on magnetic bead separation and maldi-tof mass spectrometry. Asian Pac J Cancer Prev, 14, 6069-75.
13. Ding YL, Wang QS, Zhao WM, et al (2012). Expression of smoothened protein in colon cancer and its prognostic value for postoperative liver metastasis. Asian Pac J Cancer Prev, 13, 4001-5.
14. Dong H, Tang J, Li LH, et al (2013). Serum carbohydrate antigen 19-9 as an indicator of liver metastasis in colorectal carcinoma cases. Asian Pac J Cancer Prev, 14, 909-13.
15. Fang WJ, Zheng Y, Wu LM, et al (2012). Genome-wide analysis of aberrant DNA methylation for identification of potential biomarkers in colorectal cancer patients. Asian Pac J Cancer Prev, 13, 1917-21.
16. Fromowitz FB, Viola MV, Chao S, et al (1987). ras p21 expression in the progression of breast cancer. Hum Pathol, 18, 1268-75.
17. Gao CM, Ding JH, Li SP, et al (2013). Polymorphisms in XRCC1 gene, alcohol drinking, and risk of colorectal cancer: a case-control study in jiangsu province of China. Asian Pac J Cancer Prev, 14, 6613-8.
18. Goyama S, Mulloy JC (2011). Molecular pathogenesis of core binding factor leukemia: current knowledge and future prospects. Int J Hematol, 94, 126-33.
19. Heidarnia MA, Monfared ED, Akbari ME, et al (2013). Social determinants of health and 5-year survival of colorectal cancer. Asian Pac J Cancer Prev, 14, 5111-6.
20. Hu Y, Wang JL, Tao HT, et al (2013). Expression and significance of TSGF, CEA and AFP in patients before and after radical surgery for colon cancer. Asian Pac J Cancer Prev, 14, 3877-80.
21. Huang GL, Guo HQ, Yang F, et al (2012). Activating transcription factor 1 is a prognostic marker of colorectal cancer. Asian Pac J Cancer Prev, 13, 1053-7.
22. Jacobs K, Van Gele M, Forsyth R, et al (2010). P-cadherin counteracts myosin II-B function: implications in melanoma progression. Mol Cancer, 9, 255.
23. Krasna MJ, Flancbaum L, Cody RP, et al (1988). Vascular and neural invasion in colorectal carcinoma. Incidence and prognostic significance. Cancer, 61, 1018-23.
24. Krendel M, Mooseker MS (2005). Myosins: tails (and heads) of functional diversity. Physiology, 20, 239-51.
25. Lee WS, Seo G, Shin HJ, et al (2008). Identification of differentially expressed genes in microsatellite stable HNPCC and sporadic colon cancer. J Surg Res, 144, 29-35.
26. Li ZT, Zhang L, Gao XZ, et al (2013). Expression and significance of the Wip1 proto-oncogene in colorectal cancer. Asian Pac J Cancer Prev, 14, 1975-9.
27. Liebig C, Ayala G, Wilks JA, et al (2009). Perineural invasion in cancer: a review of the literature. Cancer, 115, 3379-91.
28. Lohsiriwat V, Anubhonganant W, Prapasrivorakul S, et al (2013). Outcomes of local excision for early rectal cancer: a 6-year experience from the largest university hospital in Thailand. Asian Pac J Cancer Prev, 14, 5141-4.
29. Loikkanen I, Toljamo K, Hirvikoski P, et al (2009). Myosin VI is a modulator of androgen-dependent gene expression. Oncol Rep, 22, 991-5.
30. Lu P, Liu R, Ma EM, et al (2012). Functional analysis of B7-H3 in colonic carcinoma cells. Asian Pac J Cancer Prev, 13, 3899-903.
31. Lu Y, Liu P, Wen W, et al (2010). Cross-species comparison of orthologous gene expression in human bladder cancer and carcinogen-induced rodent models. Am J Transl Res, 3, 8-27.
32. Madrigal-Bujaidar E, Martino Roaro L, Garcia-Aguirre K, et al (2013). Grapefruit juice suppresses azoxymethane-induced colon aberrant crypt formation and induces antioxidant capacity in mice. Asian Pac J Cancer Prev, 14, 6851-6.
33. Matsuoka R, Yoshida MC, Furutani Y, et al (1993). Human smooth muscle myosin heavy chain gene mapped to chromosomal region 16q12. Am J Med Genet, 46, 61-7.
34. Pessina P, Conti V, Pacelli F, et al (2010). Skeletal muscle of gastric cancer patients expresses genes involved in muscle regeneration. Oncol Rep, 24, 741-5.
35. Qian LY, Li P, Li XR, et al (2012). Multivariate analysis of molecular indicators for postoperative liver metastasis in colorectal cancer cases. Asian Pac J Cancer Prev, 13, 3967-71.
36. Roychowdhury S, Iyer MK, Robinson DR, et al (2011). Personalized oncology through integrative high-throughput sequencing: a pilot study. Sci Transl Med, 3, 111ra21.
37. Saeed HM, Alanazi MS, Parine NR, et al (2013). Matrix metalloproteinase-2 (-1306 c>t) promoter polymorphism and risk of colorectal cancer in the Saudi population. Asian Pac J Cancer Prev, 14, 6025-30.
38. Seitz S, Korsching E, Weimer J, et al (2006). Genetic background of different cancer cell lines influences the gene set involved in chromosome 8 mediated breast tumor suppression. Gene Chromosome Canc, 45, 612-27.
39. Sisik A, Kaya M, Bas G, et al (2013). CEA and CA 19-9 are still valuable markers for the prognosis of colorectal and gastric cancer patients. Asian Pac J Cancer Prev, 14, 4289-94.
40. Vickaryous N, Polanco-Echeverry G, Morrow S, et al (2008). Smooth-muscle myosin mutations in hereditary non-polyposis colorectal cancer syndrome. Brit J Cancer, 99, 1726-8.
41. Wu HW, Gao LD, Wei GH (2013). hMSH2 and nm23 expression in sporadic colorectal cancer and its clinical significance. Asian Pac J Cancer Prev, 14, 1995-8.
42. Yang L, Huang XE, Xu L, et al (2013). Role of MYH polymorphisms in sporadic colorectal cancer in China: a case-control, population-based study. Asian Pac J Cancer Prev, 14, 6403-9.
43. Zhang YY, Chen B, Ding YQ (2012). Metastasis-associated factors facilitating the progression of colorectal cancer. Asian Pac J Cancer Prev, 13, 2437-44.